Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Who should not take GLP-1 medicines
Failure of these systems results in the accumulation of misfolded or aggregated proteins, organelle dysfunction, cellular injury, and disease progression across a wide spectrum of conditions, including neurodegeneration, cancer, cardiovascular and metabolic diseases
Acknowledgements The authors would like to thank Thomas Rohban, MD, and Magalie El Hajj, PharmD, from Partner 4 Health (Paris, France) for providing medical writing support in accordance with Good Publication Practice (GPP3) guidelines
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 digital issues and online access to articles 111,21 per year only 9,27 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
US$ 25.53
US$ 22.27
US$ 21.59
US$ 29.10
US$ 25.39
US$ 25.30
US$ 20.81
US$ 26.58
US$ 21.92
